OPHTHOTECH CORP has a total of 88 patent applications. It increased the IP activity by 50.0%. Its first patent ever was published in 2004. It filed its patents most often in United States, EPO (European Patent Office) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are LECLERC DENIS, PEPTIMED INC and ACADEMISCH ZIEKENHUIS LEIDEN H.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 15 | |
#2 | EPO (European Patent Office) | 9 | |
#3 | Canada | 6 | |
#4 | Japan | 6 | |
#5 | Taiwan | 6 | |
#6 | WIPO (World Intellectual Property Organization) | 6 | |
#7 | Australia | 5 | |
#8 | China | 4 | |
#9 | Israel | 4 | |
#10 | New Zealand | 4 | |
#11 | Singapore | 4 | |
#12 | Argentina | 3 | |
#13 | Hong Kong | 3 | |
#14 | Republic of Korea | 3 | |
#15 | Brazil | 2 | |
#16 | Chile | 2 | |
#17 | Mexico | 2 | |
#18 | Philippines | 2 | |
#19 | Colombia | 1 | |
#20 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Peptides | |
#5 | Object sterilising | |
#6 | Implantable devices | |
#7 | Syringes |
# | Name | Total Patents |
---|---|---|
#1 | Adamis Anthony P | 29 |
#2 | Calias Perry | 29 |
#3 | Patel Samir | 28 |
#4 | Shima David | 24 |
#5 | Everett Richard | 14 |
#6 | Chang Byeong Seon | 13 |
#7 | Masonson Harvey | 13 |
#8 | Samir Patel | 6 |
#9 | Shima David T | 5 |
#10 | Guyer David | 3 |
Publication | Filing date | Title |
---|---|---|
WO2019040397A1 | A method for treating or preventing neovascular age-related macular degeneration | |
CA2958017A1 | Methods for treating or preventing ophthalmological conditions | |
AU2015204293A1 | Combination therapy for the treatment of ocular neovascular disorders | |
WO2015027219A2 | Apparatus and methods useful for dispensing one or more substances from a single container | |
EP3019243A1 | Methods for treating or preventing ophthalmological conditions | |
MX2014014445A | Compositions comprising an anti-pdgf aptamer and a vegf antagonist. | |
US2013323242A1 | Compositions comprising an anti-pdgf aptamer and a vegf antagonist | |
AU2012265582A1 | Combination therapy for the treatment of ocular neovascular disorders | |
CA2760687A1 | Methods for treating or preventing ophthalmological diseases | |
US2011110932A1 | Combination treatment for ocular diseases | |
KR20120116994A | Combination therapy for the treatment of ocular neovascular disorders |